International Endovascular Corporation Establishes New Headquarters in Carlsbad, California
New 8,100+ square-foot headquarters integrates research, development, manufacturing, quality systems, and corporate operations to accelerate the development and commercialization of the DABRA™ Laser & Catheter system and future endovascular technologies.
CARLSBAD, Calif. — July 2026 — International Endovascular Corporation (IEVC) today announced the establishment of its new corporate headquarters at 3280 Grey Hawk Court, Carlsbad, California, expanding the company's capabilities to support the development and commercialization of advanced endovascular technologies.
The new 8,100+ square-foot facility integrates research and development, engineering, manufacturing, quality systems, and corporate operations under one roof. Purpose-built to support the complete medical device development lifecycle, the headquarters features 2 hardwall cleanrooms (650 ft2 and 170 ft2), wet laboratories, optical and electronics laboratories, engineering workspaces, manufacturing operations, and administrative offices.
"Establishing our new headquarters represents an important milestone in IEVC's growth," said Dean Irwin, Chief Executive Officer of IEVC. "By bringing our engineering, manufacturing, quality, and business operations together in a single integrated facility, we have created an environment that supports rapid collaboration, efficient execution, and continued innovation in vascular medical technology."
The expanded facility provides the infrastructure to support continued advancement of the DABRA™ excimer laser & catheter platform, future product development initiatives, manufacturing operations, regulatory activities, and strategic growth opportunities.
The headquarters also serves as the operating base for CyMeda, Inc., whose experienced engineering and manufacturing team supports IEVC's technology development and commercialization activities.
IEVC welcomes prospective customers, strategic partners, and qualified investors to visit its new headquarters. Qualified investors may also request access to the company's secure virtual data room.
About International Endovascular Corporation
International Endovascular Corporation (IEVC) is a medical device company focused on acquiring, developing, and commercializing innovative technologies for the treatment of vascular disease. The company is advancing the DABRA™ excimer laser platform and other technologies designed to improve the treatment of peripheral artery disease through minimally invasive endovascular intervention.
Contact:
Dean Irwin, CEO
©2026